Bruce Jackson
Stock Analyst at Benchmark
(1.34)
# 3,394
Out of 4,761 analysts
118
Total ratings
33.91%
Success rate
-11.19%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLTE Belite Bio | Maintains: Buy | $57 → $79 | $57.00 | +38.60% | 8 | Jan 21, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $11.10 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $49.26 | +31.95% | 7 | Jan 13, 2025 | |
| HUMA Humacyte | Maintains: Buy | $15 → $17 | $3.54 | +380.23% | 13 | Dec 23, 2024 | |
| CLNN Clene | Maintains: Buy | $90 → $84 | $4.43 | +1,796.16% | 7 | Nov 22, 2024 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.55 | - | 3 | Nov 22, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $3 | $0.62 | +386.30% | 8 | Nov 22, 2024 | |
| MLSS Milestone Scientific | Reiterates: Speculative Buy | $1.25 | $1.04 | +20.19% | 2 | Nov 20, 2024 | |
| BFRI Biofrontera | Reiterates: Buy | $7 | $1.11 | +530.63% | 7 | Nov 15, 2024 | |
| HOTH Hoth Therapeutics | Reiterates: Speculative Buy | $3 | $1.06 | +183.02% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.80 | +78.57% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $5.00 | +500.00% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $2 | $0.50 | +296.43% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $1.57 | +982.80% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.39 | +1,626.62% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $25 | $4.81 | +419.75% | 6 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.65 | +88.68% | 5 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.08 | +362.96% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.61 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $16.87 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $7 | $0.99 | +607.07% | 4 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.69 | +21,580.22% | 1 | Aug 8, 2022 |
Belite Bio
Jan 21, 2025
Maintains: Buy
Price Target: $57 → $79
Current: $57.00
Upside: +38.60%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $11.10
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $49.26
Upside: +31.95%
Humacyte
Dec 23, 2024
Maintains: Buy
Price Target: $15 → $17
Current: $3.54
Upside: +380.23%
Clene
Nov 22, 2024
Maintains: Buy
Price Target: $90 → $84
Current: $4.43
Upside: +1,796.16%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.55
Upside: -
Unicycive Therapeutics
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.62
Upside: +386.30%
Milestone Scientific
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $1.04
Upside: +20.19%
Biofrontera
Nov 15, 2024
Reiterates: Buy
Price Target: $7
Current: $1.11
Upside: +530.63%
Hoth Therapeutics
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.06
Upside: +183.02%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.80
Upside: +78.57%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $5.00
Upside: +500.00%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $2
Current: $0.50
Upside: +296.43%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $1.57
Upside: +982.80%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.39
Upside: +1,626.62%
Jun 3, 2024
Reiterates: Speculative Buy
Price Target: $25
Current: $4.81
Upside: +419.75%
Apr 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.65
Upside: +88.68%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.08
Upside: +362.96%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.61
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $16.87
Upside: -
Jun 22, 2023
Reiterates: Speculative Buy
Price Target: $7
Current: $0.99
Upside: +607.07%
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.69
Upside: +21,580.22%